Skip to search.
 All Ordinaries Up 0.59%
Streaming
Ticker Tape: On

More On BIT.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

Financials

Biotron Limited (BIT.AX)

-ASX
0.11 Up 0.01(5.00%) 17 Apr 15:58
Add to Portfolio
Prev Close:0.10
Open:0.11
Bid:0.11
Ask:0.11
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.11 - 0.11
52wk Range:0.07 - 0.32
Volume:258,175
Avg Vol (3m):1,495,810
Market Cap:23.97M
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in AUD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):25.60
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biotron Limited develops and commercializes novel small molecule antiviral therapeutics targeting Hepatitis C virus (HCV) and HIV-1 in Australia. Its lead drug includes the BIT225, a viroporin inhibitor, which is in Phase 2 clinical trials used fo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback